Jeremy Bender, Ph.D., M.B.A.
Board Member
Aura Biosciences, Inc. (AURA)Equibles does not estimate personal net worth.
Get an email with a short summary when Aura Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get AURA alertsAbout Jeremy Bender, Ph.D., M.B.A.
Jeremy Bender, Ph.D., M.B.A. is recorded as Board Member at Aura Biosciences, Inc. (AURA) since July 7, 2026. Aura Biosciences, Inc. reported in an 8-K filed July 8, 2026 that Jeremy Bender, Ph.D., M.B.A. was appointed Class II director, effective July 7, 2026. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Elisabet de los Pinos (CEO and Board Member), Natalie Holles (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer) and 7 others.
“On July 3, 2026, the Board of Directors (the "Board") of Aura Biosciences, Inc. (the "Company") increased the size of the Board from six to seven directors and unanimously appointed Jeremy Bender, Ph.D., M.B.A., as a Class II director, effective July 7, 2026 (the "Effective Date"), to fill the newly created vacancy.”
Affiliation history
-
Current
2026-07-07–present
Company network
Leadership on record at Aura Biosciences, Inc.
- Elisabet de los Pinos CEO, Board Member
- Natalie Holles CEO, Board Member
- Amy Elazzouzi CFO, Chief Accounting Officer
- Anthony Gibney CFO
- Julie B. Feder CFO
- Mark De Rosch COO
- Susan Abu-Absi COO
- Mark Plavsic CTO
- Conor Kilroy General Counsel
- David Johnson Board Member